Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
Matthew S. Block(Mayo Clinic in Arizona), Lisa E. Paddock(Rutgers, The State University of New Jersey), Yukie T. Bean(Oregon Health & Science University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Peter A. Fasching(Universitätsklinikum Erlangen), Claus Høgdall(Copenhagen University Hospital), Jenny Chang‐Claude(Universität Hamburg), Florian Heitz(Kliniken Essen-Mitte), Robert A. Vierkant(Mayo Clinic), James M. Flanagan(QIMR Berghofer Medical Research Institute), Estrid Høgdall(University of Copenhagen), Douglas A. Levine(New York University), Susanne K. Kjær(Copenhagen University Hospital), Ian Campbell(The University of Sydney), William R. Bamlet(Mayo Clinic), Marc T. Goodman(Cedars-Sinai Medical Center), Alice S. Whittemore(Cancer Registry of Norway), Bridget Charbonneau(Cedars-Sinai Medical Center), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Andreas du Bois(Kliniken Essen-Mitte), Lene Lundvall(University of Copenhagen), Robert Brown(Emerson College), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Nicolas Wentzensen(National Cancer Institute), Irene Orlow(Memorial Sloan Kettering Cancer Center), Tanja Pejović(Oregon Health & Science University), Jolanta Kupryjańczyk(Cedars-Sinai Medical Center), Hoda Anton Culver(University of California, Irvine), Philipp Harter(Kliniken Essen-Mitte), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Usha Menon(University of South Florida), Daniel Cramer(Brigham and Women's Hospital), Joellen Schildkraut, Beth Y. Karlan(University of California, Los Angeles), Alexander Hein, Paul D.P. Pharoah(Cedars-Sinai Medical Center), Ira Schwaab(Cancer Institute of New South Wales), Jacek Gronwald(International Hereditary Cancer Center), James Paul(Beatson West of Scotland Cancer Centre), Galina Lurie(Cancer Prevention Institute of California), Celeste Leigh Pearce(University of Southern California), Mary Anne Rossing(Fred Hutch Cancer Center), Stanley B. Kaye(Royal Marsden Hospital), Laura E. Hays(Oregon Health & Science University), Diana Eccles(Princess Anne Hospital), Zachary C. Fogarty(Mayo Clinic in Florida)
Cited by 15
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k